News for 'drug manufacturing'

Regulator cuts prices of 100 drugs

Regulator cuts prices of 100 drugs

Rediff.com6 Jun 2007

The move is in line with the NPPA's recent policy of putting a cap on prices.

Uzbekistan cough syrup deaths: Noida firm loses production licence

Uzbekistan cough syrup deaths: Noida firm loses production licence

Rediff.com12 Jan 2023

A team of central agencies and the Uttar Pradesh drug department had carried out an inspection at the firm's office in Noida on December 29 and taken six more samples for testing.

Lupin receives US FDA nod for drug

Lupin receives US FDA nod for drug

Rediff.com28 Jul 2003

Lupin Ltd received US Food & Drug Administration's approval for its abbreviated new drug application for Cefuroxime Axetil tablets.

Ranbaxy, US co tie up for HIV drug

Ranbaxy, US co tie up for HIV drug

Rediff.com25 Sep 2006

Ranbaxy Laboratories Ltd said on Monday it has entered into a licensing agreement with US-based Gilead Sciences Inc for manufacturing and marketing of Active Pharmaceutical Ingredient and formulations containing anti-HIV drug Tenofovir.

Ranbaxy gets final FDA nod for drug

Ranbaxy gets final FDA nod for drug

Rediff.com10 Jun 2004

Ranbaxy Laboratories on Thursday said that it had received final approval from US Food and Drug Administration to manufacture and market Ciprofloxacin.

Pharma majors open new R&D chapter

Pharma majors open new R&D chapter

Rediff.com28 Jun 2007

Part research being farmed out to medical colleges, universities to cut cost and time.

Exodus of pharma cos from Maharashtra

Exodus of pharma cos from Maharashtra

Rediff.com16 Mar 2005

Over 50 pharmaceutical companies have scaled down operations in Maharashtra and Gujarat and are moving out to states like Uttaranchal and Himachal Pradesh following steep hike in excise duty in the Union Budget.

Why price control for drugs is wrong

Why price control for drugs is wrong

Rediff.com19 Jun 2013

For the poorest 20 per cent of Indians, the expenditure on medicines alone is 85 per cent of what they spend on their health, according to the National Sample Survey.

Abbott's antibiotic in India on the list of banned drugs

Abbott's antibiotic in India on the list of banned drugs

Rediff.com14 Mar 2016

A notice issued by the Indian Health Ministry at the weekend said that a government-appointed committee of experts had found that the banned combinations were "likely to involve risk to human beings, whereas safer alternatives to the said drug are available."

US ruling gives Indian pharma a booster dose

US ruling gives Indian pharma a booster dose

Rediff.com3 May 2007

In a landmark judgment likely to benefit Indian generic drug manufacturers in a big way, the US Supreme Court has ruled against patenting of products with slight modifications.

Messiah of the masses: Cipla's global crusade for low cost drugs

Messiah of the masses: Cipla's global crusade for low cost drugs

Rediff.com24 Dec 2014

Drug maker Cipla always fought a lone battle to make drugs affordable in India.

Piramal, French co to make anti-chikungunya drug

Piramal, French co to make anti-chikungunya drug

Rediff.com16 Oct 2006

Nicholas Piramal has signed an MoU with a French pharma company to manufacture an anti-chikungunya drug.

Dilip Shanghvi's success: From a start-up to India's largest drug maker

Dilip Shanghvi's success: From a start-up to India's largest drug maker

Rediff.com11 Mar 2015

Dilip Shanghvi founded Sun Pharma in 1983.

India to be hub for US drug firm

India to be hub for US drug firm

Rediff.com4 Oct 2005

Indian drug makers face heat of US regulator's crackdown

Indian drug makers face heat of US regulator's crackdown

Rediff.com23 Jun 2013

Data also show that several other leading domestic pharma companies have recalled their products from the US

'Pharma cos face probs in distribution of drugs in J-K'

'Pharma cos face probs in distribution of drugs in J-K'

Rediff.com15 Sep 2014

Pharmaceutical companies, which are sending across medical aid for flood affected people in Jammu and Kashmir, claim to be facing difficulties in distribution of drugs.

Sharapova's future to be decided in London

Sharapova's future to be decided in London

Rediff.com18 May 2016

Maria Sharapova will attend an International Tennis Federation anti-doping hearing in London on Wednesday, British media reported, with the Russian facing a possible ban of up to four years for failing a drugs test at the Australian Open.

Covovax as Covid booster jab to be available on CoWIN soon

Covovax as Covid booster jab to be available on CoWIN soon

Rediff.com10 Apr 2023

Covovax is likely to be available on the portal in a few days at a price of Rs 225 per dose plus applicable GST.

Ramdev, Balkrishna apologise to SC for Patanjali ads

Ramdev, Balkrishna apologise to SC for Patanjali ads

Rediff.com9 Apr 2024

In two separate affidavits filed in the apex court, Ramdev and Balkrishna tendered unqualified apology for the 'breach of the statement' recorded in the November 21 last year order of the apex court.

After US, Germany bans export of Ranbaxy's Dewas plant drugs

After US, Germany bans export of Ranbaxy's Dewas plant drugs

Rediff.com3 Dec 2014

The company did not comply to the 'good manufacturing practice' norms.

Ranbaxy sues US FDA for revoking drug approvals

Ranbaxy sues US FDA for revoking drug approvals

Rediff.com18 Nov 2014

FDA had cancelled Ranbaxy's approvals to launch generic Nexium, Valcyte

2 Indian vaccine makers sitting on stockpile of 250mn Covid doses

2 Indian vaccine makers sitting on stockpile of 250mn Covid doses

Rediff.com28 Dec 2022

According to respective company sources, Biological E is holding 200 million doses of its COVID-19 vaccine Corbevax while Bharat Biotech is sitting on a stockpile of 50 million doses of Covaxin.

Sun Pharma's Halol facility listed under USFDA import alert

Sun Pharma's Halol facility listed under USFDA import alert

Rediff.com8 Dec 2022

Sun Pharmaceutical Industries Ltd on Thursday said its Halol facility in Gujarat has been listed under import alert by the USFDA with products manufactured at the unit now are subject to refusal of admission in the US market. The development follows an inspection of the facility by the US Food and Drug Administration (USFDA) from April 26 to May 9, 2022. "We now wish to inform you that the company has received a communication from the USFDA stating that the facility has been listed under Import Alert," Sun Pharma said in a regulatory filing.

Pfizer to cut 10,000 jobs worldwide

Pfizer to cut 10,000 jobs worldwide

Rediff.com23 Jan 2007

The drastic measure will help the company to counter its failure to meet the pricing by generic drug manufacturers.

PLI scheme for more sectors likely in Budget 2023

PLI scheme for more sectors likely in Budget 2023

Rediff.com20 Jan 2023

The government is likely to extend fiscal incentives for production of toys, bicycles and leather and footwear in the forthcoming budget as it looks to expand production linked incentive (PLI) scheme to cover more high-employment potential sectors, sources said. The government has already rolled out the scheme with an outlay of about Rs 2 lakh crore for as many as 14 sectors, including automobiles and auto components, white goods, pharma, textiles, food products, high efficiency solar PV modules, advance chemistry cell and speciality steel. The scheme aims to make domestic manufacturing globally competitive and create global champions in manufacturing, and it is yielding solid results, sources said.

Ban on 5 medicines of Ramdev's Divya Pharmacy revoked

Ban on 5 medicines of Ramdev's Divya Pharmacy revoked

Rediff.com13 Nov 2022

Amending the earlier order, the authority on Saturday issued a fresh one allowing the firm to continue the production of these medicines.

US nod for Ranbaxy's AIDS drug

US nod for Ranbaxy's AIDS drug

Rediff.com1 Jun 2005

Cough syrups exported to Uzbekistan, not sold in India

Cough syrups exported to Uzbekistan, not sold in India

Rediff.com29 Dec 2022

The Central Drugs Standard Control Organisation (CDSCO) has initiated a probe in connection with the death of 18 children in Uzbekistan allegedly linked to Marion Biotech.

Ranbaxy gets FDA nod for drugs

Ranbaxy gets FDA nod for drugs

Rediff.com9 Sep 2004

Ranbaxy Laboratories has received tentative approval from the US Food and Drug Administration to manufacture and market Fosinopril Sodium and Hydrochlorothiazide tablets in 10 mg/12.5 mg and 20 mg/12.5 mg strengths

US court raps Dr Reddy's Labs

US court raps Dr Reddy's Labs

Rediff.com28 Feb 2004

India's generic drug manufacturer, Dr Reddy's Laboratories, suffered a setback when a US' Court of Appeals ruled that it infringed on Pfizer Pharmaceutical company's patent for the blood pressure medicine Norvasc.

Generics key to pharma growth

Generics key to pharma growth

Rediff.com9 Feb 2004

Reliance Retail buys majority stake in Netmeds for Rs 620 cr

Reliance Retail buys majority stake in Netmeds for Rs 620 cr

Rediff.com19 Aug 2020

Reliance Retail Ventures Ltd has acquired a majority equity stake in digital pharma market place Netmeds for a cash consideration of around Rs 620 crore, Reliance Industries said in a late night statement on Tuesday.